Novel Biomarker Discovery
Value proposition
Unbiased discovery of biomarkers for any indication and context of use.
Service list
RNA seq of NDEs
Proteomic analysis of NDEs
In-vitro drug response biomarker discovery
NDE Compatibility and Verification Testing
Test/monitor target engagement or off-target effect in the brain. Help determine effective or safe doses. Define the therapeutic window in humans.
Detection & quantification of biomarkers within NDEs.
Customization of exosome-based assays for specific targets.
Biomarker assay analytical validation and clinical incorporation.
Why Choose NeuroDex
At NeuroDex, we are committed to advancing the field of neurological diagnostics through cutting-edge biomarker discovery and innovative testing solutions. Our proprietary technologies and research capabilities enable us to deliver precise and reliable insights for early disease detection, monitoring treatment efficacy, and advancing therapeutic research.
Operational Excellence
NeuroDex's operational excellence is built on rigorous quality standards, including GLP and CLIA compliance, ensuring reliable, reproducible, and high-quality biomarker analysis.
Personalized Insights
NeuroDex's personalized insights approach delivers customized biomarker panels designed to precisely detect and monitor disease markers, supporting targeted research and improved patient outcomes.
Scientific Precision
NeuroDex's scientific precision is driven by advanced isolation and detection techniques that ensure accurate biomarker identification, supporting reliable diagnostics and robust research outcomes.
Collaborative Approach
NeuroDex's collaborative approach involves partnering with clinical and research teams to develop tailored biomarker solutions, fostering seamless integration and impactful research outcomes.
Biomarker Discovery Solutions
NeuroDex provides advanced biomarker discovery solutions that integrate seamlessly into clinical workflows. Our neuron-derived extracellular vesicle (NDE) panels enable precise disease detection, monitoring, and treatment evaluation. Validated under GLP and CLIA standards, our solutions support personalized diagnostics, enhance patient care, and optimize therapeutic strategies.
Regulatory Compliance
Clinical Trial Support
Enhanced Diagnostic Accuracy
Personalized Monitoring
Parkinson's disease and synucleopathy
*a-syn biomarker, novel biomarker discovery
ALS
*TDP43 biomarker, novel biomarker discovery
Alzheimer's disease
*Tau/pTau, A-syn, biomarkers, novel biomarker discovery
Neuroinflamation
*NF-kB biomarker, novel biomarker discovery
Autophagy, Brain injury
*LC3 biomarker, novel biomarker discovery